Zus Health Secures $33M to Scale AI-Native Health Data Infrastructure Beyond Legacy EHR Silos
HIT Consultant · 1d ago
Sanofi
Medicine & Biotech · covered by 11 outlets this week · tracked since 2026-10-27
Press: 1 mainstream 13 specialist 3 independent outlet-days
Background
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 19h ago. Not medical advice; how the ratings work.
Coverage
cstranslation pending
Šéf Sanofi v ČR Basantani: Moderní léky existují, Češi ale čekají stovky dní. Co je třeba změnit?
Zdravotnický deník · 1d ago
pttranslation pending
Manejo do mieloma múltiplo reúne eficiência, qualidade de vida e humanização
Medicina S/A · 1d ago
The Drug Enterprise in the Age of AI
KFF · 1d ago
randomized trial
StockWatch: Nurix Nosedives as Sanofi Halts Phase I Immunology Candidate
GEN Genetic Engineering News · 3d ago
Sanofi stops development of Nurix-partnered immune drug
BioPharma Dive · 7d ago
study
STAT+: Coming readout of Kymera eczema trial is a high-stakes moment in a bid to rival Dupixent
STAT Biotech · 9d ago
Sanofi eyeing pipeline deals ahead of Dupixent patent loss
Pharmaphorum · 12d ago
study
BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting Fabry Drug
MedCity News · 13d ago
Behind the scenes of 3 Big Pharma layoffs
BioSpace · 14d ago
Enable Injections, Sanofi obtain approval for on-body myeloma therapy in Japan
Drug Delivery Business · 20d ago
Sanofi’s Qfitlia® (Fitusiran) receives marketing authorisation in India for Haemophilia treatment
BioSpectrum India · 21d ago
Sanofi’s twin sites win ISPE’s overall 2026 Facility of the Year Award
Pharma Manufacturing · 23d ago
Mixtard, Ultracet and Lantus lead September brand declines
BioSpectrum India · 27d ago